However, the company’s operating loss of $2.28 million was also an increase of 11.5 percent compared to 2012’s third quarter. The company’s operating expenses increased from $3.48 million in 2012 to $4.58 million in 2013.
More Articles on Devices:
NuVasive Q3 Income at $7k, Up Nearly 250% From Last Year
ArthroCare Profits Increase 4.27% in Q3
Device Companies — 7 Key Notes — Zimmer, Boston Scientific & More
